, 2009 本发明提供一种用于甲醇水蒸气重整制氢的复合氧化物催化剂。催化剂是以ZnO为主活性组分，包括Cr2O3、ZrO2、CeO2等的复合氧化物作为催化和热稳定助剂和载体，以解决现有甲醇水蒸气重整制氢技术中催化剂活性低和稳定性差的缺陷。本发明催化剂可以在较高反应温度430～480℃、甲醇和水总气时空速为5000～30000h-1条件下，进行甲醇水蒸气重整反应，重整气中氢含量大于74％(mol)，450小时后甲醇转化率仍在93％以上，该催化剂活性高、稳定性好 ...
袁 权, 陈光文, 李淑莲, 焦凤军
core
[Chronic iron overload induces diminished ovarian reserve in mice <i>via</i> iron metabolism dysregulation-mediated oxidative stress and endocrine dysfunction]. [PDF]
Nan Fang Yi Ke Da Xue Xue BaoYu J, Chu J, Liang C.
europepmc +1 more source
, 2014 本发明涉及一种新型高效负载型多组分催化剂的制备，具体过程分为如下：（1）使用多元醇、PVP作为还原剂和稳定剂，控制还原温度100-200°C，时间为2-6小时，在惰性气氛下获得高分散的铜铂核-壳纳米粒子；（2）分离该纳米复合物，并浸渍到相应的载体上；（3）在液相条件下，氢气0.5-5bar，pH值为2-6，原位在铂壳表面沉积纳米铁岛，形成相应的纳米铜铂核壳结构稳定的纳米铁岛催化材料。该方法适用性广、易于控制、过程重复性好、操作安全可靠，其合成纳米颗粒具有尺寸均一、高分散、成本低等特点 ...
包信和, 傅强, 郭晓光
core
[Formononetin downregulates P53/SAT1/ACSL4 pathway-mediated ferroptosis to improve hypoxic-ischemic brain injury in neonatal mice]. [PDF]
Nan Fang Yi Ke Da Xue Xue BaoGuo T +8 more
europepmc +1 more source
, 2010 本发明涉及一种手性二胺-质子酸催化剂及其制备和应用，该催化剂的结构如下所示，该催化剂可用于醛(比如芳香醛，脂肪醛等)的不对称Aldol，Michael加成等涉及碳碳键形成的有机合成反应之中，该催化剂显示出较高的活性和高的光学选择性(高达95％的ee值)，且该催化剂可回收和循环利用 ...
高强, 李灿
core
[Glutamine-induced autophagy exacerbates muscle atrophy in cachectic nude mice: a multi-omics analysis]. [PDF]
Nan Fang Yi Ke Da Xue Xue BaoLi Z +5 more
europepmc +1 more source
[Chinese medicine Gandouling attenuates brain injury in hepatolenticular degeneration mice by inhibiting ferroptosis via the SIRT1/FoxO3 signaling pathway]. [PDF]
Zhejiang Da Xue Xue Bao Yi Xue BanWu K +5 more
europepmc +1 more source
[<i>Jianpi Zishen</i> Formula improves renal damage in mice with systemic lupus erythematosus by inhibiting p53-MDM2 signaling axis-mediated ferroptosis]. [PDF]
Nan Fang Yi Ke Da Xue Xue BaoLi Y, Huang C, Pang L, Zhu Z, Li M.
europepmc +1 more source
[Role of m6A methylation modification in photoaging and ultraviolet-induced skin cancers]. [PDF]
Zhong Nan Da Xue Xue Bao Yi Xue BanHou Y, Zhang X, Liu J, Wu J.
europepmc +1 more source
[Therapeutic efficacy of ASS1 combined with LOLA in the treatment of hyperammonemia in mice]. [PDF]
Zhong Nan Da Xue Xue Bao Yi Xue BanLuo T, Ming Z, Zou Z, Luo Z.
europepmc +1 more source